NX-1607 is a Cbl-b inhibitor. NX-1607 reduces tumor growth in colon and triple negative breast cancer. NX-1607 demonstrates enhanced NK and CD8+ T cell activity in the TME.
MedKoo Cat#: 150004
Name: NX-1607
CAS#: 2573775-59-2
Chemical Formula: C30H34F3N5O
Exact Mass: 537.2715
Molecular Weight: 537.63
Elemental Analysis: C, 67.02; H, 6.37; F, 10.60; N, 13.03; O, 2.98
The following data is based on the product molecular weight 537.63 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.
| Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
|---|---|---|---|
| 1 mM | 1.15 mL | 5.76 mL | 11.51 mL |
| 5 mM | 0.23 mL | 1.15 mL | 2.3 mL |
| 10 mM | 0.12 mL | 0.58 mL | 1.15 mL |
| 50 mM | 0.02 mL | 0.12 mL | 0.23 mL |
